Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results.

Journal of Clinical Microbiology
Raquel GirardelloA C Gales

Abstract

Polymyxins have been the only alternative therapeutic option for the treatment of serious infections caused by multidrug-resistant Acinetobacter baumannii or Pseudomonas aeruginosa isolates. For this reason, it is of crucial importance that susceptibility tests provide accurate results when testing these drug-pathogen combinations. In this study, the effect of cation concentration variability found on different commercial brands of Mueller-Hinton agar (MHA) for testing polymyxin B susceptibility was evaluated. The polymyxin B susceptibilities determined using Etest and disk diffusion were compared to those determined by the CLSI reference broth microdilution method. In general, the polymyxin B MIC values were higher when determined by Etest than when determined by broth microdilution against both A. baumannii and P. aeruginosa isolates. A high very major error rate (10%) was observed, as well as a trend toward lower MICs, compared to those determined by broth microdilution when the Merck MHA was tested by Etest. Poor essential agreement rates (10 to 70%) were observed for P. aeruginosa when all MHA brands were tested by Etest. Although an excellent categorical agreement rate (100%) was seen between the disk diffusion and broth ...Continue Reading

References

Dec 1, 1979·Antimicrobial Agents and Chemotherapy·T P FelegieR B Yee
Dec 1, 1971·The Journal of Infectious Diseases·S D DavisR J Wedgwood
Sep 1, 1969·Journal of Clinical Pathology·L P Garrod, P M Waterworth
Jan 1, 1982·The Medical Clinics of North America·J Horton, G A Pankey
Mar 28, 1998·Antimicrobial Agents and Chemotherapy·J J DrabickA S Cross
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A S LevinS F Costa
Oct 12, 2000·Diagnostic Microbiology and Infectious Disease·P C FuchsS D Brown
Oct 3, 2002·The Journal of Antimicrobial Chemotherapy·Jennifer AndrewsAnna King
Jan 11, 2007·Annals of Clinical Microbiology and Antimicrobials·Hamidou TraoreRuth McNerney
Aug 19, 2007·Annals of Clinical Microbiology and Antimicrobials·Inneke M van der HeijdenSilvia F Costa
Oct 25, 2008·PLoS Genetics·Alexander Y MitrophanovEduardo A Groisman
Jan 16, 2009·Journal of Clinical Microbiology·Carlos Fernández-MazarrasaLuis Martínez-Martínez
Jun 17, 2009·Antimicrobial Agents and Chemotherapy·Mark D AdamsRobert A Bonomo

❮ Previous
Next ❯

Citations

Dec 11, 2013·Diagnostic Microbiology and Infectious Disease·Marta TatoRafael Cantón
Sep 12, 2015·Current Opinion in Microbiology·Paul M Dunman, Andrew P Tomaras
Aug 28, 2014·Critical Reviews in Microbiology·Jaime A LabarcaManuel Guzmán-Blanco
Nov 12, 2016·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Flávia RossiAlberto José da Silva Duarte
Oct 3, 2015·PLoS Genetics·Alexandro Rodríguez-RojasJens Rolff
Sep 6, 2014·Bioconjugate Chemistry·Anas AllamIsabelle Artaud
Aug 30, 2017·Journal of Bacteriology·Martina PasquaFrancesco Imperi
Jul 8, 2015·Antimicrobial Agents and Chemotherapy·Carlo BonchiPaolo Visca
Sep 14, 2016·Antimicrobial Agents and Chemotherapy·Caio Augusto Martins AiresAna Paula D'Alincourt Carvalho-Assef
Sep 12, 2019·Expert Review of Anti-infective Therapy·Konstantina DafopoulouSpyros Pournaras
Dec 16, 2017·The Journal of Antimicrobial Chemotherapy·Felipe Fernández-CuencaUNKNOWN Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)
Jun 5, 2020·Advances in Wound Care·Ida C Thaarup, Thomas Bjarnsholt
Dec 14, 2018·Journal of Clinical Microbiology·Fereshteh EzadiReza Mirnejad
Jan 12, 2019·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Lucie Bardet, Jean-Marc Rolain
Nov 15, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yoshinori Yamano
Jan 10, 2019·ACS Infectious Diseases·Marcella WidyaDavid A Six

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Clinical Microbiology
Carlos Fernández-MazarrasaLuis Martínez-Martínez
Clinical Microbiology Reviews
Romney M HumphriesGeorge Sakoulas
Antimicrobial Agents and Chemotherapy
Markus A ZeitlingerUrsula Theuretzbacher
© 2021 Meta ULC. All rights reserved